These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33749845)

  • 1. Healthcare utilization and costs of psychiatric and somatic comorbidities associated with newly diagnosed adult ADHD.
    Garcia-Argibay M; Pandya E; Ahnemark E; Werner-Kiechle T; Andersson LM; Larsson H; Du Rietz E
    Acta Psychiatr Scand; 2021 Jul; 144(1):50-59. PubMed ID: 33749845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register-based study.
    Du Rietz E; Jangmo A; Kuja-Halkola R; Chang Z; D'Onofrio BM; Ahnemark E; Werner-Kiechle T; Larsson H
    J Child Psychol Psychiatry; 2020 Sep; 61(9):959-968. PubMed ID: 32115717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
    Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
    Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.
    Secnik K; Swensen A; Lage MJ
    Pharmacoeconomics; 2005; 23(1):93-102. PubMed ID: 15693731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease burden and direct medical costs of incident adult ADHD: A retrospective longitudinal analysis based on German statutory health insurance claims data.
    Libutzki B; May M; Gleitz M; Karus M; Neukirch B; Hartman CA; Reif A
    Eur Psychiatry; 2020 Oct; 63(1):e86. PubMed ID: 32998793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of illness and health care resource utilization in adult psychiatric outpatients with attention-deficit/hyperactivity disorder in Europe.
    Karlsdotter K; Bushe C; Hakkaart L; Sobanski E; Kan CC; Lebrec J; Kraemer S; Dieteren NA; Deberdt W
    Curr Med Res Opin; 2016 Sep; 32(9):1547-56. PubMed ID: 27171913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time after time: failure to identify and support females with ADHD - a Swedish population register study.
    Skoglund C; Sundström Poromaa I; Leksell D; Ekholm Selling K; Cars T; Giacobini M; Young S; Kopp Kallner H
    J Child Psychol Psychiatry; 2024 Jun; 65(6):832-844. PubMed ID: 38016697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD.
    Kawatkar AA; Knight TK; Moss RA; Sikirica V; Chu LH; Hodgkins P; Haim Erder M; Nichol MB
    Value Health; 2014 Sep; 17(6):661-8. PubMed ID: 25236989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Guerin A; Childress A
    Child Adolesc Psychiatry Ment Health; 2024 Jul; 18(1):80. PubMed ID: 38978130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Expenditures Associated with Attention-Deficit/Hyperactivity Disorder Among Adults in the United States by Age, 2015-2019.
    Witrick B; Zhang D; Su D; Li Y; McCall WV; Hendricks B; Shi L
    J Gen Intern Med; 2023 Jul; 38(9):2082-2090. PubMed ID: 36781580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark.
    Jennum P; Hastrup LH; Ibsen R; Kjellberg J; Simonsen E
    Eur Neuropsychopharmacol; 2020 Aug; 37():29-38. PubMed ID: 32682821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis.
    Hodgkins P; Montejano L; Sasané R; Huse D
    Prim Care Companion CNS Disord; 2011; 13(2):. PubMed ID: 21977356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study.
    Polyzoi M; Ahnemark E; Medin E; Ginsberg Y
    Neuropsychiatr Dis Treat; 2018; 14():1149-1161. PubMed ID: 29765219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
    PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic burden of attention-deficit/hyperactivity disorder across the lifecourse.
    Libutzki B; Neukirch B; Reif A; Hartman CA
    Acta Psychiatr Scand; 2024 Aug; 150(2):105-117. PubMed ID: 38804256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.
    Hauck TS; Lau C; Wing LLF; Kurdyak P; Tu K
    Can J Psychiatry; 2017 Jun; 62(6):393-402. PubMed ID: 28103079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.